CCR5 Promoter Polymorphisms Associated With Pulmonary Tuberculosis in a Chinese Han Population.
Shuyuan Liu1, Nannan Liu1, Hui Wang2
1Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, China.
Frontiers in Immunology
|March 8, 2021
Summary
Genetic variations in the CCR5 gene promoter are linked to tuberculosis susceptibility and progression. Specific CCR5 polymorphisms increase the risk of developing pulmonary tuberculosis and disease recurrence in the Chinese Han population.
Area of Science:
- Immunogenetics
- Infectious Diseases
- Human Genetics
Background:
- Tuberculosis (TB) is a significant global health issue caused by Mycobacterium tuberculosis.
- Chemokine receptors like CCR5 are crucial for immune cell responses against TB.
Purpose of the Study:
- To investigate the association between CCR5 gene promoter variations and tuberculosis infection and progression.
- To analyze the correlation between specific CCR5 polymorphisms and TB susceptibility in a Chinese Han population.
Main Methods:
- A case-control study involving 450 TB patients and 306 healthy controls.
- Sequencing was used to detect polymorphisms in the CCR5 promoter region.
- Logistic regression analysis and stratified analysis were performed.
Main Results:
- The rs2734648-G allele and rs2734648-GG genotype were significantly associated with increased TB susceptibility.
- rs2734648-GG correlated with higher susceptibility to pulmonary TB, and the rs2734648-G allele with TB recurrence.
- A specific haplotype in the CCR5 promoter showed a significantly increased risk for TB and pulmonary TB susceptibility.
Conclusions:
- CCR5 promoter polymorphisms are associated with pulmonary TB and disease progression.
- These findings highlight the role of CCR5 gene variations in TB pathogenesis within the studied population.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
17.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.3K
Pulmonary Tuberculosis V
317
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
317
Pulmonary Tuberculosis I
487
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
487
Pulmonary Tuberculosis III
597
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
597
Pulmonary Tuberculosis II
850
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
850
Pulmonary Tuberculosis IV
267
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
267


